Saturday, 04 April 2020

Japan News

  • François-Xavier Roge is Takeda's new CFO

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

    Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief financial officer (CFO), effective September 2, 2013.In his new role, M...Read more

  • Eisai seeks nod for cancer, epilepsy drug in S Africa

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Japan-based Eisai has filed two products, Halaven (eribulin) for metastatic breast cancer and Fycompa (perampanel) for epilepsy, for approval with Medicines Control Council (MCC)...Read more

  • Otsuka schizophrenia drug seeks EMA nod

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Dec, 2012

    Singapore: Otsuka Pharmaceutical and H Lundbeck's submission of a marketing authorization application (MAA) for the approval of aripiprazole depot formulation has been accepted by the Euro...Read more

  • Santen to give $7.9 mn fund to Clearside

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

    Singapore: Santen, a wholly owned subsidiary of Japan-based Santen Pharmaceuticals, and Clearside Biomedical, announced that Santen, has made an investment in Clearside Biomedical and has ...Read more

  • Takeda partners with Wipro for IT solutions

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2014

    Singapore: India based information technology, consulting and outsourcing company, Wipro, has partenerd with Japan's Takeda Pharmaceutical to provide IT services across the oranization. As...Read more

  • Affymax, Takeda recall anemia drug Omontys

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 25 Feb, 2013

    Singapore: Affymax and Takeda Pharma decided to voluntarily recall all lots of Omontys (peginesatide) injection to the user level, as a result of new post-marketing reports regarding seriou...Read more

  • Astellas completes patient recruitment in drug trial

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registration study SECURE. Isavuconazole is an investigational intravenous (IV)...Read more

  • EMA accepts market authorization plea for alogliptin

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 25 May, 2012

    Singapore: The European Medicines Agency has accepted a marketing authorization application for alogliptin, a selective dipeptidyl peptidase IV, or DPP-4, inhibitor for the treatment of typ...Read more

  • Daiichi Sankyo expands drug discovery program

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities and research institutions based in Japan, 'Take a New challenge for Dr...Read more

  • BioDiem granted Japanese patent for BDM-1

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Singapore: Australian infectious disease therapy development company BioDiem has been granted a key Japanese patent for antimicrobial compound, BDM-I. The compund acts against a range of ...Read more

  • Zecotek and Hamamatsu Photonics join hands

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: Zecotek Photonics, a developer of leading-edge photonics technologies for medical, industrial and scientific markets, announced that its wholly owned subsidiary Zecotek Imaging S...Read more

  • Oramed granted patent in Japan for its POD Tech

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

    Singapore: Israel-based Oramed Pharmaceuticals, a developer of oral drug delivery systems, has announced receiving two additional patent approvals for its platform Protein Oral Delivery (PO...Read more

  • Novo Nordisk insulin analogue gets Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

    Singapore: Novo Nordisk announced that the Japanese Ministry of Health, Labour and Welfare has approved Ryzodeg (insulin degludec/insulin aspart) for the treatment of diabetes. In Japa...Read more

  • Mitsubishi Tanabe, Cytochroma end agreement

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Singapore: Japanese company Mitsubishi Tanabe Pharma and Canada-based Cytochroma have terminated a license agreement executed in 2008. The two companies have mutually agreed to the termina...Read more

  • Will Ranbaxy, Wockhardt incidents affect brand India?

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 29 May, 2013

    When the Indian generic sector forayed into the global arena almost two decades back, the affordability of its treatment options and its reliable quality drew eyeballs from potential market...Read more

  • Takeda Gemini II trial shows positive results

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase III trial. The trial evaluated v...Read more

  • Japanese stem cell firm ReproCell expands to US

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

    Singapore: ReproCELL, a Japanese stem cell technology company, has opened the company's first branch and US office in Boston. ReproCELL is the third Japanese life sciences company to have e...Read more

  • Japanese firm suspends trial of ArQule candidate

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

    Singapore: Japanese pharmaceutical company Kyowa Hakko Kirin temporarily suspended patient enrollment in an international phase III clinical study evaluating the combination of ARQ 197 (tiv...Read more